Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry - PubMed (original) (raw)
Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry
Siyi Zhang et al. Chem Res Toxicol. 2006 Oct.
Abstract
Crotonaldehyde, a mutagen and carcinogen, reacts with deoxyguanosine (dGuo) in DNA to generate a pair of diastereomeric 1,N(2)()-propanodeoxyguanosine adducts (Cro-dGuo, 2), which occur in (6S,8S) and (6R,8R) configurations. They can also be formed through the consecutive reaction of two acetaldehyde molecules with dGuo. Cro-dGuo adducts inhibit DNA synthesis and induce miscoding in human cells. Considering their potential role in carcinogenesis, we have developed a sensitive and specific liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method to explore the presence of Cro-dGuo adducts in DNA from various human tissues, such as liver, lung, and blood. DNA was isolated from human tissues and enzymatically hydrolyzed to deoxyribonucleosides. [(15)N(5)]Cro-dGuo was synthesized and used as an internal standard. The Cro-dGuo adducts were enriched from the hydrolysate by solid-phase extraction and analyzed by LC-ESI-MS/MS using selected reaction monitoring (SRM). This method allows the quantitation of the Cro-dGuo adducts at a concentration of 4 fmol/micromol dGuo, corresponding to about 1 adduct per 10(9) normal nucleosides starting with 1 mg of DNA, with high accuracy and precision. DNA from human liver, lung, and blood was analyzed. The Cro-dGuo adducts were detected more frequently in human lung DNA than in liver DNA but were not detected in DNA from blood. The results of this study provide quantified data on Cro-dGuo adducts in human tissues. The higher frequency of Cro-dGuo in lung DNA than in the other tissues investigated is potentially important and deserves further study.
Figures
Figure 1
Chromatograms obtained upon LC-ESI-MS/MS analysis of 0.5 fmol standard Cro-dGuo (2) (top) and 10 fmol [15N5]Cro-dGuo ([15N5]2) (bottom). Peak areas were 4.9*104 for (6S, 8S)-2, 5.5*104 for (6R, 8R)-2, 1.1*106 for (6S, 8S)-[15N5]2, and 1.2*106 for (6R, 8R)-[15N5]2.
Figure 2
Calibration curves for Cro-dGuo (2, 0.5–50 fmol) and [15N5]Cro-dGuo ([15N5]2, 10 fmol): ■, (6S, 8S)-2, R2 = 1.0000;, ρ, (6R, 8R)-2, R2 = 1.0000.
Figure 3
Chromatograms obtained upon LC-ESI-MS/MS analysis of calf thymus DNA. Calf thymus DNA was enzymatically hydrolyzed, purified by SPE, and analyzed (panel A); or the eluants from SPE were treated with NaOH and NaBH4 and analyzed (panel B). Transitions of m/z 340 → m/z 224 and m/z 345 → m/z 229 correspond to the ring-opened products of the analyte and internal standard, N2_-(4-hydroxybut-2-yl)dGuo and [15N5]N2_-(4-hydroxybut-2-yl)dGuo, respectively. The early eluting peak was produced from (6_R, 8R)-2 and the late eluting peak from (6_S, 8S)-2.
Figure 4
Relationship of added to detected Cro-dGuo (2). Various amounts of standard adduct 2 were added to calf thymus DNA (0.91 mg) containing [15N5]2 and analyzed by the method described in the text. Adduct 2 in calf thymus DNA [9.80 fmol/mg DNA for (6S, 8S)-2 and 8.49 fmol/mg DNA for (6R, 8R)-2] was subtracted from each amount detected. Each point represents a triplicate measurement. A, (6S, 8S)-2, R2 = 0.9986; B, (6R, 8R)-2, R2 = 1.0000.
Figure 5
Chromatograms obtained upon LC-ESI-MS/MS-SRM analysis of DNA from human liver and lung. A and C, DNA from human liver; B, DNA from the same human liver as in A, to which 2 fmol of each diastereomer of Cro-dGuo was added; D, DNA from human lung.
Scheme 1
Formation of _1,N2_-propanodeoxyguanosine adducts in the reactions of crotonaldehyde or acetaldehyde with dGuo.
Similar articles
- Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Zhang S, Villalta PW, Wang M, Hecht SS. Zhang S, et al. Chem Res Toxicol. 2007 Apr;20(4):565-71. doi: 10.1021/tx700023z. Epub 2007 Mar 27. Chem Res Toxicol. 2007. PMID: 17385896 Free PMC article. - Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine.
Wang M, Yu N, Chen L, Villalta PW, Hochalter JB, Hecht SS. Wang M, et al. Chem Res Toxicol. 2006 Feb;19(2):319-24. doi: 10.1021/tx0502948. Chem Res Toxicol. 2006. PMID: 16485909 Free PMC article. - Quantitation by Liquid Chromatography-Nanoelectrospray Ionization-High-Resolution Tandem Mass Spectrometry of Multiple DNA Adducts Related to Cigarette Smoking in Oral Cells in the Shanghai Cohort Study.
Cheng G, Guo J, Wang R, Yuan JM, Balbo S, Hecht SS. Cheng G, et al. Chem Res Toxicol. 2023 Feb 20;36(2):305-312. doi: 10.1021/acs.chemrestox.2c00393. Epub 2023 Jan 31. Chem Res Toxicol. 2023. PMID: 36719849 Free PMC article. - DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.
Hwa Yun B, Guo J, Bellamri M, Turesky RJ. Hwa Yun B, et al. Mass Spectrom Rev. 2020 Mar;39(1-2):55-82. doi: 10.1002/mas.21570. Epub 2018 Jun 11. Mass Spectrom Rev. 2020. PMID: 29889312 Free PMC article. Review. - From single DNA adducts measurement to DNA adductomics in molecular epidemiology of cancer.
Baer-Dubowska W, Szaefer H. Baer-Dubowska W, et al. Postepy Biochem. 2024 May 23;70(1):52-56. doi: 10.18388/pb.2021_509. Print 2024 May 23. Postepy Biochem. 2024. PMID: 39016235 Review.
Cited by
- Increased levels of the acetaldehyde-derived DNA adduct N 2-ethyldeoxyguanosine in oral mucosa DNA from Rhesus monkeys exposed to alcohol.
Balbo S, Juanes RC, Khariwala S, Baker EJ, Daunais JB, Grant KA. Balbo S, et al. Mutagenesis. 2016 Sep;31(5):553-8. doi: 10.1093/mutage/gew016. Epub 2016 Apr 7. Mutagenesis. 2016. PMID: 27056945 Free PMC article. - DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol.
Tang MS, Lee HW, Weng MW, Wang HT, Hu Y, Chen LC, Park SH, Chan HW, Xu J, Wu XR, Wang H, Yang R, Galdane K, Jackson K, Chu A, Halzack E. Tang MS, et al. Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108409. doi: 10.1016/j.mrrev.2021.108409. Epub 2021 Dec 20. Mutat Res Rev Mutat Res. 2022. PMID: 35690412 Free PMC article. Review. - Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Zhang S, Villalta PW, Wang M, Hecht SS. Zhang S, et al. Chem Res Toxicol. 2007 Apr;20(4):565-71. doi: 10.1021/tx700023z. Epub 2007 Mar 27. Chem Res Toxicol. 2007. PMID: 17385896 Free PMC article. - Mass spectrometric analysis of a cyclic 7,8-butanoguanine adduct of N-nitrosopyrrolidine: comparison to other N-nitrosopyrrolidine adducts in rat hepatic DNA.
Loureiro AP, Zhang W, Kassie F, Zhang S, Villalta PW, Wang M, Hecht SS. Loureiro AP, et al. Chem Res Toxicol. 2009 Oct;22(10):1728-35. doi: 10.1021/tx900238t. Chem Res Toxicol. 2009. PMID: 19761253 Free PMC article. - Occurrence, Biological Consequences, and Human Health Relevance of Oxidative Stress-Induced DNA Damage.
Yu Y, Cui Y, Niedernhofer LJ, Wang Y. Yu Y, et al. Chem Res Toxicol. 2016 Dec 19;29(12):2008-2039. doi: 10.1021/acs.chemrestox.6b00265. Epub 2016 Nov 7. Chem Res Toxicol. 2016. PMID: 27989142 Free PMC article. Review.
References
- Chung FL, Chen HJ, Nath RG. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis. 1996;17:2105–2111. - PubMed
- Wang MY, Chung FL, Hecht SS. Identification of crotonaldehyde as a hepatic microsomal metabolite formed by α-hydroxylation of the carcinogen N-nitrosopyrrolidine. Chem Res Toxicol. 1988;1:28–31. - PubMed
- Neudecker T, Eder E, Deininger C, Henschler D. Crotonaldehyde is mutagenic in Salmonella typhimurium TA100. Environ Mol Mutagen. 1989;14:146–148. - PubMed
- Chung FL, Tanaka T, Hecht SS. Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res. 1986;46:1285–1289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 CA077598/CA/NCI NIH HHS/United States
- R01 ES011297/ES/NIEHS NIH HHS/United States
- R01 ES011297-01/ES/NIEHS NIH HHS/United States
- ES-11297/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources